Amyotrophic lateral sclerosis (ALS) is a rare deadly progressive neurological disease that
primarily affects the upper and lower motor neurons with an annual incidence rate of 0.6 to …

Breakthroughs with rapid changes are the themes of the development in Neurorestoratology
this year. Given the very difficult circumstances of the persistent COVID-19 pandemic, most …

Background Acute respiratory distress syndrome (ARDS) is the devastating complication of
the new COVID-19 pandemic, directly correlated with releasing large amounts of …

Applying stem cell therapy in intractable diseases: a narrative review of decades of progress
and challenges - PMC Back to Top Skip to main content NIH NLM Logo Access keys NCBI …

Neurodegenerative diseases (NDDs), which are chronic and progressive diseases, are a
growing health concern. Among the therapeutic methods, stem-cell-based therapy is an …

Amyotrophic lateral sclerosis (ALS) is characterized by selective and progressive
neurodegenerative changes in motor neural networks. Given the system complexity …

COVID-19 disease caused by the Severe Acute Respiratory Syndrome Coronavirus 2
(SARS-CoV-2), started in December 2019 in Wuhan, China, and quickly became the global …

Epidermolysis bullosa (EB) is a rare genetic dermatosis characterized by skin fragility and
blister formation. With a wide phenotypic spectrum and potential extracutaneous …

Background Radiotherapy is a crucial treatment for most malignancies. However, it can
cause several side effects, including the development of secondary malignancies due to …

Objective Neuronata-R®(lenzumestrocel) is an autologous bone marrow-derived
mesenchymal stem cell (BM-MSC) product, which was conditionally approved by the Korean …